Addition of Aβ42 to Total Cerebral Small Vessel Disease Score Improves the Prediction for Cognitive Impairment in Cerebral Small Vessel Disease Patients
Jianping Liu,1 Weihua Zhao,2 Qinghong Gui,1 Ying Zhang,1 Zaiyu Guo,2 Wei Liu3 1Department of Neurology, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 2Department of Neurosurgery, Tianjin TEDA Hospital, Tianjin 300457, People’s Republic of China; 3Department o...
Guardado en:
Autores principales: | Liu J, Zhao W, Gui Q, Zhang Y, Guo Z, Liu W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/569af6e1e66f48bba1c0427cc4f4b6be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease
por: Nanae Ishida, et al.
Publicado: (2021) -
Total Cerebral Small Vessel Disease Burden on MRI Correlates With Cognitive Impairment in Outpatients With Amnestic Disorders
por: Yangyi Fan, et al.
Publicado: (2021) -
Clinicoradiographic and genetic features of cerebral small vessel disease indicate variability in mode of inheritance for monoallelic HTRA1 variants
por: Karthik Muthusamy, et al.
Publicado: (2021) -
Endothelial Dysfunction and Hyperhomocysteinemia-Linked Cerebral Small Vessel Disease: Underlying Mechanisms and Treatment Timing
por: Shuang Li, et al.
Publicado: (2021) -
Pre-operative Cerebral Small Vessel Disease on MR Imaging Is Associated With Cerebral Hyperperfusion After Carotid Endarterectomy
por: Xiaoyuan Fan, et al.
Publicado: (2021)